ArthroCare Corporation  

(Public, NASDAQ:ARTC)   Watch this stock  
Find more results for sinus
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.40
Shares 34.50M
Beta     -
Inst. own 114%
Aug 4, 2014
Q2 2014 ArthroCare Earnings Release (Estimated) Add to calendar
May 8, 2014
ArthroCare Special Meeting of Stockholders
May 2, 2014
Q1 2014 ArthroCare Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 6.47% 6.89%
Operating margin 9.58% 8.46%
EBITD margin - 12.49%
Return on average assets 4.28% 4.68%
Return on average equity 3.23% 4.83%
Employees 1,840 -
CDP Score - -


AUSTIN, TX 78735
United States - Map
+1-512-3913900 (Phone)
+1-302-6555049 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare�s two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It�s Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.